A research meta-analysis suggests that the anti-cancer properties of antioxidants may have been overstated, and that, in some cases, antioxidants could even have an adverse effect with regard to cancer.
Can one of the most popular beverages in the world limit or even prevent the growth of certain cancers?
This fact sheet explores possible relationships between antioxidants and cancer prevention.
Researchers from the Lustgarten Foundation and Feinberg School of Medicine at Northwestern University offer an explanation of why antioxidant supplements may do more harm than good in regard to reducing cancer development.
A compound initially developed as a treatment for high cholesterol not only halts the progression of breast cancer, but also can kill cancer cells.
Scientists identified a molecular trigger that prompts the unrestricted cell growth in cancer. A protein in the TOR signaling pathway, SREBP, controls the flow of messages to the endoplasmic reticulum (ER) to produce enough proteins and lipids to support nonstop growth.
Researchers from the University of Basel were able to show that aspirin use and smoking both influence aging processes of the female genome that are connected to colorectal cancer.
Reducing carbohydrate intake could reduce the risk of breast cancer recurrence among women whose tumor tissue is positive for the insulin-like growth factor-1 (IGF1) receptor, according to a new study.
A diet rich in dairy products may slightly extend the lives of people diagnosed with colon cancer, a new study suggests.
Clinical trials have begun for PFK-158, a small-molecule therapeutic candidate that inactivates a novel cancer metabolism target never before examined in human clinical trials.
Antiviral treatment for hepatitis B virus (HBV) may be associated with a lower risk of hepatocellular carcinoma, researchers reported.
An enzyme commonly used as a target for antidepressants may also promote prostate cancer growth, according to an international team of scientists.
Scientists have found a way to target elusive cells that suppress immune response, depleting them with peptides that spare other important cells and shrink tumors in preclinical experiments, according to a new study.
Patients who express pretreatment concern about treatment symptoms such as nausea and memory problems tend to suffer higher symptom burdens during and after anticancer treatment, suggests research.
A prospective survey found no reduction in cancer incidence in women eating organic food, but there's more to the story.
Inhibiting a single protein completely shuts down the growth of pancreatic cancer, according to new research.
A breast cancer therapy that blocks estrogen synthesis to activate cancer-killing genes sometimes loses its effectiveness because the cancer takes over epigenetic mechanisms, according to researchers.
Scientists have identified a major mitochondrial pathway that allows cancer cells to survive in a low-glucose environment.
Pancreatic stellate cells, which normally aid tissue repair, unwittingly help pancreatic cancer grow and spread in a method of cell hijack only seen before in brain and breast cancer, according to new research. The research also revealed that the process can be blocked, thereby preventing the growth and spread of the tumor.
A group of researchers discovered a promising new approach to treating leukemia by disarming a gene that is responsible for tumor progression.
Grape seed can aid the effectiveness of chemotherapy in killing colon cancer cells as well as reducing chemotherapy side effects, according to new research.
The drug cyclophosphamide may make recurrent tumors vulnerable again after they have developed resistance to cancer drugs that work by recruiting antibodies from the body's own immune system.
A new study has identified the molecular pathway that enables cancer cells to grow in areas of a tumor where oxygen levels are low, a condition called hypoxia.
Specialized fat molecules, called sphingolipids, play a key role in the survival of aggressive lymphomas caused by viruses, according to new research.
A previously known but little-studied chemical compound targets and shuts down a common cancer process, according to recent research. In studies of laboratory-grown human tumor cell lines, the drug disrupted tumor cell division and prevented growth of advanced cancer cells.
A toxin linked to a targeted monoclonal antibody has shown compelling antitumor activity in patients with non-Hodgkin lymphomas (NHLs) who were no longer responding to treatment, according to a new report.
The intestinal flora stimulates an person's immune responses to combat cancer during chemotherapy, according to newly published research.
In addition to infrequent exercise, a larger breast cup size was also linked with increased risk of breast cancer mortality in female runners and walkers.
Advanced imaging techniques may be able to distinguish which patients' tumors will respond to treatment with antiangiogenic drugs and which will not.
When colorectal cancer is targeted by the drug bevacizumab, tumors may switch dependence from VEGF-A (targeted by the drug) to related growth factors that include VEGF-C, VEGF-D, and placental growth factor.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|